Ambient particulate air pollution and acute lower respiratory infections: a systematic review and implications for estimating the global burden of disease
- First Online:
- Cite this article as:
- Mehta, S., Shin, H., Burnett, R. et al. Air Qual Atmos Health (2013) 6: 69. doi:10.1007/s11869-011-0146-3
- 2.8k Downloads
Acute lower respiratory infections (ALRI) account for nearly one fifth of mortality in young children worldwide and have been associated with exposures to indoor and outdoor sources of combustion-derived air pollution. A systematic review was conducted to identify relevant articles on air pollution and ALRI in children. Using a Bayesian approach to meta-analysis, a summary estimate of 1.12 (1.03, 1.30) increased risk in ALRI occurrence per 10 μg/m3 increase in annual average PM2.5 concentration was derived from the longer-term (subchronic and chronic) effects studies. This analysis strengthens the evidence for a causal relationship between exposure to PM2.5 and the occurrence of ALRI and provides a basis for estimating the global attributable burden of mortality due to ALRI that is not influenced by the wide variation in regional case fatality rates. Most studies, however, have been conducted in settings with relatively low levels of PM2.5. Extrapolating their results to other, more polluted, regions will require a model that is informed by evidence from studies of the effects on ALRI of exposure to PM2.5 from other combustion sources, such as secondhand smoke and household solid fuel use.
KeywordsGlobal health Air pollution ALRI Health impact assessment
Acute lower respiratory infection
Particulate matter ≤10 μm in aerodynamic diameter
Particulate matter ≤2.5 μm in aerodynamic diameter
World Health Organization
Acute lower respiratory infections (ALRI), including pneumonia and bronchiolitis of bacterial and viral origin, are the largest single cause of mortality among young children worldwide and thus account for a significant global burden of disease worldwide (Williams et al. 2002). Cases are nearly always diagnosed clinically, based on severe respiratory symptoms, where ALRI is characterized by acute-onset cough or difficulty in breathing with fast breathing for age and severe ALRI defined as acute cough or difficulty in breathing with indrawing of the lower chest wall necessitating hospital admission (Nair et al. 2010). According to recent estimates, these infections cause nearly one fifth of mortality in children under the age of 5 years, with 90% of ALRI deaths being directly attributable to pneumonia. A substantial fraction of the burden is experienced by populations in Asia and Africa, with 134 and 131 million cases of lower respiratory infections occurring each year in Asia and Africa, respectively, out of an overall global annual total of 429.2 million cases for all ages.
Outdoor air pollution has been associated with increased ALRI mortality and with increased symptoms, admissions to hospitals, and ER visits. The bulk of the evidence on mortality and hospital admissions from pneumonia have comes from studies of short-term exposures to lower concentrations of outdoor air pollution in developed countries (Braga et al. 2001; Zanobetti et al. 2000). A small number of studies have also been conducted in developing countries (Romieu et al. 2002). Toxicologic evidence suggests that exposure to particulate air pollution can cause pulmonary inflammation and affect host defenses against infection (Samet et al. 2006).The World Health Organization (WHO) estimated that exposure urban outdoor PM2.5 caused approximately 25,600 deaths and over 862,000 lost years of healthy life due to ALRI in 2000 (Cohen et al. 2004).
This paper describes a systematic review and meta-analysis conducted to quantify the risk of ALRI associated with ambient concentrations of PM2.5. This estimate will be used along with evidence from other combustion sources, including household solid fuel use and secondhand smoke (SHS), to derive PM2.5 concentration–response (C–R) function for incidence of child ALRI in the next update of the burden of disease from outdoor air pollution.1
Systematic review of ALRI literature
PubMed search string: (ALRI OR ARI OR pneumonia OR respiratory illness OR respiratory infection OR respiratory disease OR fast breathing OR chest indrawing OR fast breath* OR rapid breath* OR raised respiratory rate OR RSVOR bronchiolitis OR streptococcus pneumoniae OR pneumonococcus OR haemophilus influenza OR h. influenza OR respiratory tract diseases) AND (air pollution OR air pollutants OR air quality) AND (child OR preschool OR infant OR children*)
Search results were screened by title, then by abstract, to eliminate irrelevant articles. Potentially relevant articles were then reviewed to eliminate non-original studies (reviews, etc.), studies without children’s health endpoints, and studies reporting only respiratory symptoms prevalence, asthma, and allergy (non-relevant outcomes).
Approach to meta-analysis
We estimated a distribution of the true relative risk for ALRI occurrence associated with ambient PM2.5 based on longer-term (subchronic and chronic) effects studies using a Bayesian (Markov Chain Monte Carlo) approach. Because we believe that in the absence of bias the relative risk must be either greater than or equal to 1.0 (i.e., PM2.5 cannot reduce the risk of ALRI), our analyses assume that the study-specific results are derived from a gamma distribution specified by a shape and scale parameters for the summary relative risk. The gamma distribution also can characterize variation in risk among studies in a non-symmetric manner, a pattern often observed.
To estimate the risk coefficient, we ran three sequences (chains) of the Gibbs sampler for 11,000 iterations using different initial values and removed the first 1,000 samples. We assessed convergence through the use of trace plots. All estimates were obtained by WinBUGS (version 1.4.3, http://www.mrc-bsu.cam.ac.uk/bugs/). A detailed description of the approach taken is provided in “Appendix”.
Where studies presented risk estimates for multiple age groups, we focused on the results for children <2 years of age, since this is the age group most susceptible to ALRI. As a sensitivity analysis, we also compared the results of our approach with results obtained using more ‘conventional’ fixed and random effects approaches.
Systematic review of ALRI literature
- The initial search identified 5,758 publications. Screening by title and eliminating non-human studies eliminated a bulk of the initial publications, resulting in 376 articles. Remaining abstracts were screened to eliminate non-original studies (reviews, etc.), studies without children’s health endpoints, and studies reporting only respiratory symptoms prevalence, asthma, allergy (non-relevant outcomes). This eliminated another 300 publications, resulting in 74 potentially relevant publications. A summary of the studies by design and outcome category are given in Table 1.Table 1
Summary of epidemiologic studies of air pollution and ALRI identified as of September 2008
We are aware that this search strategy did not adequately capture the evidence on respiratory mortality. For example, while we are aware of a handful of studies which have focused on respiratory mortality (Ritz et al. 2006; Woodruff et al. 1997, 2006, 2008), all four cohort studies identified focused on morbidity outcomes.
The vast majority of studies have been conducted in Europe and North America (42 studies), and a substantial number of studies (24 studies) have been conducted in Latin American. Asia (four studies), the Middle East (three studies), the South Pacific/Oceania region, and Africa (zero studies) are seriously underrepresented in the literature.
Evidence from short-term studies
Time series studies
We identified five time series studies investigating the association between ambient exposure to particular matter and ALRI in young children through a systematic review of literature. Three of the studies were conducted in Brazil (Braga et al. 2001; Conceicao et al. 2001; Gouveia and Fletcher 2000; Saldiva et al. 1994), and the other two studies were carried out in Mexico (Hernandez-Cadena et al. 2007) and Chile (Ostro et al. 1999). Six of these time series studies identified a relationship between ALRI morbidity or mortality and increases in PM10 exposure, with relative risk estimates ranging from 1.00 and 1.09 for every 10-μg/m3 increase in PM10 exposure. Increased risks were observed in both of the studies conducted in Brazil, with stronger effects observed among the younger age groups. Braga et al. (2001) observed a 3% increase in respiratory admissions (relative risk (RR) 1.026 [1.022, 1.030]) for children under 3 and a 1% increase (RR 1.009 [1.001, 1.018]) in respiratory admissions among children aged 3–5. Ostro et al. (1999) found a similar risk among Chilean children under 2 years of age (RR 1.012 [1.008, 1.016]). Gouveia and Fletcher (2000) identified a 1% higher risk of infant pneumonia (RR 1.009[1.001, 1.017]) and a similar risk among the under-five age group as a whole (RR 1.005 [0.998, 1.012]). Hernandez-Cadena et al. (2007) also reported an increased risk of similar magnitude in Mexican children and infants below age 6 associated with PM10 exposure (RR 1.007 [0.987, 1.027]).
In addition to the studies identified through our systematic search, we have also summarized results from a recently published study conducted in Ho Chi Minh City, Vietnam (Collaborative Working Group (CWG) on Air Pollution Poverty and Health in HCMC 2011). The study was not quantitatively included in any summary estimate, so its inclusion should not bias any results presented here. We believe it is important to include a summary of its results because it fills a major gap in the available evidence from Asia, with some of the highest concentrations (>70 μg/m3 annual average PM10) measured among these studies.
Studies conducted in the USA, France, Australia, Vietnam, and New Zealand have found a positive association between PM exposure and ALRI admissions among children below 5 years of age (Barnett et al. 2005; Collaborative Working Group (CWG) on Air Pollution Poverty and Health in HCMC 2011; Karr et al. 2006; Segala et al. 2008). Studies that have found the strongest PM effects generally focus specifically on bronchiolitis (Karr et al. 2006; Segala et al. 2008), while most of the studies which have used a more broadly grouped disease classification have found similarly inconclusive results for PM10 (Barnett et al. 2005; Gouveia and Fletcher 2000; Hernandez-Cadena et al. 2007).
Summary of short-term studies of PM and ALRI morbidity
Annual mean (range) (μg/m3)
Risk estimate (95% CI) [single-pollutant models]
Barnett et al. 2005
Australia and New Zealand
Pneumonia and acute bronchiolitis admissions
PM2.5, PM10, NO2, SO2, CO, O3, PM0.1
1.045 (1.001, 1.092)
1.064 (1.004, 1.128)
1.020 (0.994, 1.047)
1.024 (0.981, 1.069)
Braga et al. 2001
PM10, NO2, CO, SO2, O3
1.026 (1.022, 1.030)
1.009 (1.001, 1.018)
Collaborative Working Group (CWG) on Air Pollution Poverty and Health in HCMC (2011)
Bronchiolitis and pneumonia admissions
PM10, SO2, NO2, O3
1.250 (−0.550, 3.090)
Gouveia and Fletcher 2000
PM10, NO2, CO, SO2, O3
1.009 (1.001, 1.017)
1.005 (0.998, 1.012)
Hernandez-Cadena et al. 2007
Respiratory ER visits
38.7 (range not reported; SE 17.32–29.31 per year)
1.007 (0.987, 1.027)
Karr et al. 2006
Acute bronchiolitis hospitalizations
PM2.5, NO2, CO
1.410 (1.110, 1.790)
29 1/7–34 weeks
0.990 (0.880, 0.990)
34 1/7–37 weeks
0.960 (0.890, 1.030)
37 1/7–44 weeks
0.950 (0.930, 0.980)
Ostro et al. 1999
Clinic visits due to lower respiratory symptoms (inflammatory processes affecting larynx, trachea, bronchus, or lungs)
1.012 (1.008, 1.016)
Segala et al. 2008
Bronchiolitis consultations and hospitalizations
PM10, SO2, NO2, O3, black smoke
1.060 (1.100, 1.030)
PM10, SO2, NO2, O3, black smoke
1.040 (1.020, 1.070)
Evidence from longer-term studies
Summary of longer-term studies of PM and ALRI
Brauer et al. 2002
1 to 2 years
PM2.5, NO2, soot
The adjusted ORs for interquartile increases in PM2.5 (equivalent to 3.2 μg/m3) were 1.04 [0.85–1.26] for doctor-diagnosed bronchitis and 1.12 [1.00–1.27] for doctor-diagnosed flu/serious colds. For NO2 (10.3 μg/m3), the ORs were 0.99 [0.84–1.17] for bronchitis and 1.11 [1.00–1.23] for flu/serious colds. For soot (0.54 × 10−5/m), the ORs were 0.99 [0.84–1.17] for bronchitis and 1.09 [0.98–1.21] for flu/serious colds
Hertz-Picciotto et al. 2007
1 month to 4.5 years
Below 2 years of age, the adjusted ORs for bronchitis were 1.29 [1.07–1.54] for IQR increases in ambient PAHs (equivalent to 100 ng/m3) and 1.30 [1.08–1.58] for increases in PM2.5 (equivalent to 25 μg/m3). For bronchitis in children 2 to 4.5 years of age, the ORs for exposure to the same increments of PAHs and PM2.5 were 1.56 [1.22–2.00] and 1.23 [0.94–1.62], respectively
Karr et al. 2007
0 to 1year
PM2.5, NO2, CO, O3
PM2.5 exposures were associated with increased risk of bronchiolitis hospitalization (per 10 μg/m3 increase, adjusted OR = 1.09 [1.04–1.14]). Ozone was associated with reduced risk in the single-pollutant model, but this relation did not persist in multipollutant models including PM2.5
Karr et al. 2009
0 to 1 year
PM2.5 exposures (7 day, 30 day, 60 day, lifetime) were associated with increased risk of bronchiolitis hospitalization, with the strongest effects associated with lifetime exposures (per 10 μg/m3 increase, adjusted OR = 1.04 [0.83–1.29]) at average exposure concentrations of 11.6–12.6 μg/m3. Similar risks associated with all bronchiolitis and RSV bronchiolitis observed
Muhling et al. 1984
0 to 4 years
The results show a definitive connection between a high rate of hospital admissions for respiratory symptoms and high levels of SO2 and dust. This association was particularly marked in areas with high levels of both pollutants
Pouliou et al. 2008
9 to 12 years
The association between the occurrence of the outcome “cold goes to chest” in children and total suspended particulates was weak (OR 1.01 [1.005, 1.019]). But children were slightly more likely to experience the symptom if TSP pollution increased by 1 μg/m3
Muhling et al. (1984) conducted a retrospective study on the association between air pollution and children’s (aged 0–4) hospitalizations for croup and obstructive bronchitis (Muhling et al. 1984). The study compared residential areas with different SO2 and dust concentration. Despite several efforts, we were unable to obtain a full text version of the study.
The cohort in Brauer et al. (2002) consisted of 3701 infants and children ages 2 years and younger from the Prevention and Incidence of Asthma and Mite Allergy study, a prospective birth cohort recruited between 1996 and 1997 from rural and urban communities in northern, western, and central parts of the Netherlands (Brauer et al. 2002). Using logistic regression analysis, Brauer et al. compared physician-diagnosed bronchitis from parental questions to measurements of PM2.5 at 40 individual monitoring sites combined with GIS data on traffic variability. The average concentration of PM2.5 was 16.9 μg/m3 during the exposure period based on measurements conducted for four 2-week periods dispersed throughout each year. Thus, the study provides evidence at the lower end of the exposure–response curve, with min and max PM2.5 concentrations of 13.5 and 25.2 μg/m3, respectively. Note that these are within the reference levels used in Hertz-Picciotto et al. (2007) (described below). After adjustment for season, temperature, and other covariates (parental education, environmental tobacco smoke (ETS), breastfeeding, presence of allergens, region of residence, siblings, ethnicity, indoor combustion sources, age of mother at time of birth), the investigators found positive but statistically insignificant associations for bronchitis and air pollution in children below 2 years of age.
The cohort in Hertz-Picciotto et al. (2007) consisted of a subset of 452 children age 0–4.5 years from the Pregnancy Outcome Study, a prospective birth cohort recruited between 1994 and 1999 from the Czech districts of Teplice or Prachatice (Hertz-Picciotto et al. 2007). Using logistic regression analysis, Hertz-Picciotto et al. compared physician-diagnosed bronchitis from pediatric medical records of physician visits and hospitalizations to data collected from PM2.5 monitoring data. The average concentration of PM2.5 was 22.3 μg/m3 during the exposure period based on measurements performed daily in November–March, every third day in April–June, and September–October, and every sixth day in July–August of each year. After adjustment for season, temperature, and other covariates (age of child, current breastfeeding status, ETS, year of birth and sex), the investigators found positive associations for bronchitis and air pollution in children below 4.5 years of age with stronger associations for longer pollutant-averaging periods; 1.30 (1.08, 1.58) increased risk of bronchiolitis was observed for every 25 μg/m3 increase in PM2.5, with 30-day average concentrations of PM2.5 of 22.3 μg/m3 observed. The highest associations were observed among children 2–4.5 years of age at concentrations greater than 50 μg/m3.
The recent re-analysis of the Hamilton children’s cohort study using land-use regression to estimate exposures (Pouliou et al. 2008) revealed stronger associations between children’s respiratory health and air pollution exposure than were found in the previous analyses. Increased exposure to TSP was associated with respiratory symptoms as well as pulmonary function. While this study does not provide C–R function estimates, it does provide additional biological plausibility (via pulmonary function evidence) for the association between long-term exposures to particulate pollution and children’s respiratory health, albeit for an older age group.
The 18,595 cases and 169,572 controls in Karr et al. (2007) were identified from a California Office of Statewide Health Planning and Development data set that linked the birth data for South Coast Air Basin between 1995 and 2000 to hospital records for the first year of life (Karr et al. 2007). Cases were defined as all infants (<1 year of age) who had a hospital discharge of bronchiolitis in the first year of life. Using conditional logistic regression analysis, Karr et al. compared hospitalization discharge records of bronchiolitis to zip code linked PM2.5 data from 17 monitoring stations. The average concentration of PM2.5 was 25.0 μg/m3 during the exposure period based on daily average measurements performed every third day throughout each year. “Subchronic” exposures were defined as the average daily pollutant levels for the 30 days prior to hospitalization, while “chronic exposure” was defined as the mean monthly levels from birth to date of hospitalization. After matching cases and controls on age, gestational age, and season of birth and adjusting for season, temperature, and other covariates (sex, parity, chronic lung disease, cardiac or pulmonary anomalies, insurance category, ethnicity, and maternal education), the investigators found strong associations for bronchiolitis and longer-term exposures to air pollution in infants below 1 years of age, with an association between PM2.5 exposures and increased risk of bronchiolitis hospitalization (per 10 μg/m3 increase, adjusted odds ratio (OR) = 1.09 [1.04–1.14]).
The 2604 cases and 23,354 controls in Karr et al. (2009) were identified from the Washington State Birth Events Registry database that linked the birth data for Puget Sound between 1997 and 2003 to hospital records for the first year of life (Karr et al. 2009). Cases were defined as all infants who had a hospitalization discharge of bronchiolitis in the first year of life. Using conditional logistic regression analysis, Karr et al. compared hospitalization discharge records of bronchiolitis to data from PM2.5 ambient monitors within 20 km of the subject’s birth residence. The average concentration of PM2.5 was 12.1 μg/m3 during the exposure period based on daily average measurements performed every third day throughout each year.
After matching cases and controls on date of birth, gestational age, and length of birth hospitalization and adjusting for season, temperature, and other covariates (residential proximity to traffic, maternal smoking during pregnancy, race/ethnicity, maternal education, insurance category, sex, parity and prenatal care), the investigators found some positive and some inverse but statistically insignificant associations for bronchiolitis and subchronic (30 days prior to hospitalization), chronic (60 days prior to hospitalization), and lifetime (mean daily levels from birth to date of hospitalization) exposures to air pollution in infants below 1 years of age. PM2.5 exposures were associated with increased risk of bronchiolitis hospitalization, with stronger effects observed with longer averaging times; lifetime exposures were associated with a 4% increase in hospitalizations (adjusted OR = 1.04 [0.83–1.29] per 10 μg/m3 increase) at average exposure concentrations of 11.6–12.6 μg/m3. Over 91% of cases were diagnosed during the winter months (from November to April), and similar risks were observed for “all bronchiolitis” and “RSV bronchiolitis.”
ALRI risk per 10 μg/m3 PM2.5: a comparison of approaches
Beta (per unit PM2.5)
Variation between cohort
Individual study results
Brauer et al. (2002)
Hertz-Picciotto et al. (2007)
Karr et al. (2007)
Karr et al. (2009)
Fixed effects model
Random effects model
9.99 × 10−7
3.59 × 10−3
Based on the results of this review, each 10-μg/m3 increase in long-term ambient PM2.5 concentrations is associated with around a 12% increased risk of ALRI incidence. This finding is similar to the results of the last review of this literature, published 9 years ago, which estimated a 4–12% increase in ALRI for every 20-μg/m3 increase in daily PM2.5 exposure (Romieu et al. 2002).
The previous review encompassed a broader age range (children up to 15 years of age) and a wider range of health outcomes, including respiratory symptoms and both upper and lower respiratory infections (Romieu et al. 2002). Of the 42 studies reviewed, only three studies focused specifically on pneumonia, and only one of these studies was a panel study with the potential to assess effects of long-term effects (Pino et al. 1998). Only three studies were conducted in developing countries of Asia, the region where populations experience the highest exposures and the greatest burden of ALRI attributable to air pollution (Cohen et al. 2004; HEI International Scientific Oversight Committee 2004; Smith et al. 2004), and only three of the studies had data on PM2.5. There were no studies in some regions, such as Africa, with large burdens of disease due to ALRI and growing levels of urban air pollution.
This systematic review suggests that the situation has improved to some extent, with incremental evidence from more polluted regions. The results from additional short-term studies suggest that the health effects of air pollution continue to be observed at higher concentrations and across a range of geographic locations. When the first estimates of the burden of disease from air pollution were made, mortality in children under 5 years of age was estimated based on a meta-analysis of five short-term (time series) studies of PM10 and daily mortality (Cohen et al. 2004). Based on the results of the meta-analysis, each 10-μg/m3 increase in ambient PM10 concentrations above 7.5 up to 50 μg/m3 was associated with a 1% (95% confidence interval (CI) 0.9–3.1%) increase in daily mortality from ARI in children aged 0–4 years. The shape of the concentration–response function was assumed to be linear between 7.5 and 50 μg/m3, with city-specific PM2.5 concentrations not allowed to exceed 50 μg/m3 and the PM2.5/PM10 ratio assumed to be 0.5.
Perhaps the most important recent addition to the literature, particularly with respect to estimating of the global burden of ALRI attributable to air pollution, are the cohort studies that relate ALRI occurrence to annual average PM2.5 concentrations. These studies provide estimates of effect on ALRI incidence, a metric preferable to mortality for estimating the global burden of ALRI due to air pollution. The cohort studies also differ from the majority of studies of PM and ALRI morbidity in that they provide estimates of effects in terms of PM2.5 rather than PM10. PM2.5 is the most consistent and robust indicator of air pollution from combustion sources that can be estimated for all global regions (Cohen et al. 2004; van Donkelaar et al. 2010). These studies also quantify the excess risk of ALRI due to cumulated, longer-term exposure to PM2.5 and were therefore the focus of our quantitative meta-analysis.
Air pollution and respiratory mortality
Studies of outdoor air pollution and ALRI have focused on morbidity outcomes rather than mortality. Those studies which have focused on mortality have generally used the much broader “respiratory mortality” as an outcome. While the systematic search strategy employed here did not fully capture studies of air pollution and neonatal or child respiratory mortality, we know many studies of air pollution and respiratory mortality.
Associations between particulate matter and postneonatal respiratory mortality
Woodruff et al. 1997
US non-low birth weight infants
Low PM10, 11.90–28.00
Medium PM10, 28.01–40.0
1.08 (0.87, 1.33)
High PM10, 40.01–68.80
1.40 (1.05, 1.85)
1.20 (1.06, 1.36)
US low birth weight infants
Low PM10, 11.90–28.00
Medium PM10, 28.01–40.0
0.93 (0.73, 1.18)
High PM10, 40.01–68.80
1.18 (0.86, 1.61)
1.05 (0.91, 1.22)
Ritz et al. 2006
California infants 7–12 months of age
Low PM10, <37.6 μg/m3
Medium PM10, 37.6 to < 52.6 μg/m3
1.55 (0.88, 2.73)a
High PM10, ≥52.6 μg/m3
2.42 (1.15, 5.10)a
Woodruff et al. 2006
Per 10 μg/m3 increase in PM2.5
2.15 (1.15, 4.02)
2.13 (1.12, 4.05)b
Woodruff et al. 2008
Per IQR increase (11 μg/m3) in PM10
1.18 (1.06, 1.31)c
1.16 (1.06, 1.27)d
Per IQR increase (7 μg/m3) in PM2.5
1.05 (0.87, 1.23)d
Results in the context of evidence from other combustion source pollution
The capacity for combustion-derived air pollution to affect resistance to infection is well-documented (Thomas and Zelikoff 1999). More recent studies suggest a role for fine particles (PM2.5; Zelikoff et al. 2003). Effects on airway resistance, epithelial permeability, and macrophage function have been associated with various components of the complex mixture of air pollution generated by indoor and outdoor sources. There has also been considerable recent interest in the role of particle-associated transition metals, such as iron, in producing oxidative stress in the lung (Ghio 2004; Ghio and Cohen 2005), which has been hypothesized to be a common factor in a range of adverse effects of air pollution on the cardiovascular and respiratory systems (Kelly 2003). PM-associated transition metals have also been associated with altered host defenses in rats (Zelikoff et al. 2002).
Consistent with the evidence from toxicological studies, recent reviews of the epidemiologic literature on ALRI in young children and exposure to combustion source pollution, including air pollution from outdoor and indoor sources, as well as secondhand smoke, demonstrate a consistent association between ALRI and air pollution exposure. Exposure to air pollution from indoor combustion of solid fuels has also been consistently associated with increased incidence and mortality risk in 14 studies in developing countries (Smith et al. 2004). A recent meta-analysis by Dherani and colleagues found that young children exposed to household air pollution from unprocessed household solid fuel use had a 1.8 (95% CI 1.5–2.2) fold greater risk of pneumonia compared to unexposed children (Dherani et al. 2008). The definition of ALRI varies among the different studies, with studies relying on maternal recall most likely to have lower specificity and possibly poorer validity. Sensitivity analyses, however, did not identify any substantial effects resulting from differences in outcome assessment or other aspects of study design, thus strengthening the credibility of the summary estimate reported. While two recent studies have attempted to measure levels of air pollution (Ezzati 2005; Ezzati and Kammen 2001), the vast majority of studies rely on qualitative indicators of household air pollution.
Children’s exposure to SHS, defined as having one or both parents who smoke indoors, has also been associated with increased incidence of ALRI infections and hospital admissions (U.S. Department of Health and Human Services 2006). Similar to the studies on ambient air pollution and ALRI, the vast majority of studies in the SHS evidence base used clinical definitions of illness; only a small proportion actually had data on confirmed RSV infections (U.S. Department of Health and Human Services 2006). Increased risks are greatest for maternal smoking, with evidence suggesting that exposure may increase the likelihood of infection or make infections more severe (U.S. Department of Health and Human Services 2006). Higher risks are observed for younger children, with children aged 3–6 years estimated to have about one third the risk of children aged 0–2 years (Li et al. 1999), with recent estimates suggesting that around 165,000 children under five die from LRI caused by exposure to secondhand smoke each year (Öberg et al. 2011).
It is difficult to estimate the independent effects of exposure to ambient PM from different combustion sources, particularly when one source dominates total exposure. Nonetheless, the evidence indicates that adverse effects of exposure to outdoor air pollution can be estimated even in populations where total exposure to combustion-derived PM is dominated by PM from other sources, including smoking and household air pollution from cooking with solid fuels. For example, in an analysis of long-term exposure to PM2.5 pollution and mortality in the American Cancer Society cohort, which includes smokers and nonsmokers, the effects of air pollution on all-cause, cardiopulmonary, and lung cancer mortality remained after adjustment for smoking status (Pope et al. 2002). In stratified analyses of the same cohort, while the strongest risks were observed in never-smokers, former and current smokers also experienced increased risks of cardiopulmonary and lung cancer mortality (Pope et al. 2002). Similarly, analyses of long-term exposure to air pollution and cardiovascular disease incidence in women found consistent, strong associations between PM2.5 exposure and cardiovascular events after controlling for smoking and after stratifying by smoking status (Miller et al. 2007). In addition, a recent systematic review of the epidemiology on air pollution and health in rapidly developing countries of Asia found that the prevalence of respiratory symptoms in adults and children remained associated with residence in more polluted Chinese cities after controlling for tobacco smoke exposure and household air pollution from solid fuel use (HEI International Scientific Oversight Committee 2010).
Implications for estimating global burden of disease
Although most studies, both of short- and longer-term exposure, have been conducted in places where ALRI does not account for a substantial burden of disease, the major determinant of the burden ALRI mortality across global regions is not incidence, but rather differences in case fatality rates (CFR). For example, only 1–3% of child mortality is due to ALRI in the countries where the longer-term studies reviewed here were conducted compared to at least 15% of deaths in much of South Asia, Sub-Saharan Africa, and Latin America (World Health Organization 2010). These are also areas where household air pollution from cooking and heating with solid fuels is not an issue. Thus, the generalizability of these results to areas with higher concentrations, and different patterns of disease must be considered when conducting health impact assessments.
Regional differences in CFR are strongly driven by susceptibility (young children in less developed regions are much more likely to be malnourished or immunocompromised, for example) and timely access to adequate treatment. Although ALRI incidence is higher, it is not evident that developing countries have higher incidence of ALRI of bacterial origin, or lower incidence of viral infection; estimates of RSV-associated ALRI are highly variable by country and region, for example (Nair et al. 2010). Moreover, as the evidence base uses clinical criteria for diagnosing ALRI, at present we are unable to determine whether air pollution may increase the severity of and/or possibly susceptibility to ALRI differently depending on whether the illness is viral or bacterial in origin. Thus, the extrapolation of estimates for mortality based on developed country research is likely to be problematic, since these countries will have low case fatality rates.
There are striking differences in the public health implications of air pollution for regions that vary widely in population size and per capita incidence of ALRI. For example, while the USA has twice as many children under five as Mexico (United States Census Bureau 2011), due to differences in national estimates of ALRI incidence (0.026 and 0.29 cases per child per year in the USA and Mexico, respectively (Rudan et al. 2004)), a 10-μg/m3 increase in PM2.5 exposure would result in nearly 66,000 additional ALRI cases in the USA but nearly 372,000 additional cases in Mexico. Similarly, Mexico and India are estimated to have the same rate of ALRI incidence (Rudan et al. 2004), but with India’s much larger population of young children (United States Census Bureau 2011), a similar 10-μg/m3 increase in PM2.5 exposure would result in over four million new cases of ALRI. Although these calculations assume a linear concentration–response function over the range of concentrations experienced in these countries, the public health implications of increased exposure to particulate pollution would still likely be much greater in countries with large populations of young children and high incidence of ALRI even if the slope of the concentration–response function decreased at higher concentrations.
The cohort studies reviewed here were conducted in developed countries with relatively low levels of air pollution; the highest average PM2.5 concentration reported in these studies is 25 μg/m3, while concentrations in less developed countries can be several times greater (Sivertsen 2006; van Donkelaar et al. 2010). Estimating the global burden of ALRI due to fine particulate air pollution will require developing a concentration–response function across this broad range of ambient concentrations. In the absence of direct evidence on the effects exposure to higher levels of outdoor PM2.5, this function should be informed by evidence on ALRI risk associated with exposure to PM2.5 from other combustion sources, such as SHS and household solid fuel use. Recent work by Pope et al. (2009) on cardiovascular mortality suggests a general approach (Pope et al. 2009), and new results from a randomized trial of ALRI risk due to indoor burning of solid fuels may provide the required estimates for household air pollution (Bruce et al. 2007).
Global Burden of Disease (GBD) 2010 is the first major effort since the original GBD 1990 study to carry out a complete systematic assessment of the data on all diseases and injuries and produce comprehensive and comparable estimates of the burden of diseases, injuries, and risk factors for two time periods, 1990 and 2005. GBD is a multi-center collaboration funded by the Bill and Melinda Gates Foundation and led by the Institute for Health Metrics and Evaluation at the University of Washington, with key collaborating institutions including WHO, Harvard University, Johns Hopkins University, and the University of Queensland. For more information, visit www.globalburden.org.
The systematic review in this work was partially supported by a grant for Child Health Epidemiology Reference Group to the US Fund for UNICEF and for the Global Burden of Diseases, Injuries, and Risk Factors Study. Both grants were from the Bill & Melinda Gates Foundation. The sponsors of the study had no role in study design, data collection, data analysis, data interpretation, writing of the report, or decision to submit manuscript. We are grateful to our colleagues in the expert working group on ambient air pollution in the Global Burden of Diseases, Injuries, and Risk Factors Study 2010; to Victor Miranda for extracting the results from the ESCALA study; to Nigel Bruce and John Balmes for their insight on global patterns in ALRI incidence; and to Morgan Younkin for his administrative assistance.
The views expressed in this paper are those of the authors and do not necessarily reflect the views of the Health Effects Institute or its sponsors.
Conflict of interest
The authors declare that they have no conflict of interest.
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.